{
    "nctId": "NCT06503393",
    "briefTitle": "SENOVIE France - Therapeutic Mobility and Breast Cancer",
    "officialTitle": "SENOVIE France - Therapeutic Mobility and Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Circumstances of breast cancer diagnosis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged 18 or more\n* Women who consult in one of the partner hospitals of the study\n* For groups 1: women born in a country of sub-Saharan Africa\n* For group 2: women born in France\n* Have been diagnosed with breast cancer between the 1st of January 2014 and the 31st of December 2020. As data collection will start in 2024, this is to be able to examine women's life trajectories at least 4 years after cancer diagnosis, and maximum 10 years after their diagnosis, which is the length of the follow-up in hospital services where recruitment will take place.\n\nExclusion Criteria:\n\n* Does not speak French\n* Under 18 years old\n* Have been diagnosed with breast cancer before 2014 and after 2020",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}